Microarray analysis reveals that the expression of IGFBP-5, the precursor of AMP-IBP5, is significantly downregulated in the lesional skin of patients with AD compared to nonlesional sites, indicating that AMP-IBP5 may be involved in AD pathogenesis. The gene discussed is IGFBP5; the disease is Alzheimer disease.